Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · IEX Real-Time Price · USD
1.980
+0.060 (3.13%)
Apr 26, 2024, 3:49 PM EDT - Market closed

Can-Fite BioPharma Statistics

Total Valuation

CANF has a market cap or net worth of $10.85 million. The enterprise value is $8.53 million.

Market Cap 10.85M
Enterprise Value 8.53M

Important Dates

The next estimated earnings date is Thursday, May 30, 2024, before market open.

Earnings Date May 30, 2024
Ex-Dividend Date n/a

Share Statistics

CANF has 5.48 million shares outstanding.

Shares Outstanding 5.48M
Owned by Insiders (%) n/a
Owned by Institutions (%) 4.89%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 14.61
Forward PS n/a
PB Ratio 6.65
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 11.48
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.01.

Current Ratio 4.91
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -142.50% and return on invested capital (ROIC) is -130.43%.

Return on Equity (ROE) -142.50%
Return on Assets (ROA) -79.20%
Return on Capital (ROIC) -130.43%
Revenue Per Employee $92,875
Profits Per Employee -$954,250
Employee Count 8
Asset Turnover 0.08
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +10.67% in the last 52 weeks. The beta is 0.91, so CANF's price volatility has been similar to the market average.

Beta (1Y) 0.91
52-Week Price Change +10.67%
50-Day Moving Average 2.15
200-Day Moving Average 2.32
Relative Strength Index (RSI) 34.31
Average Volume (30 Days) 20,156

Short Selling Information

Short Interest 10,803
Short Previous Month 11,967
Short % of Shares Out 1.17%
Short % of Float n/a
Short Ratio (days to cover) 0.46

Income Statement

In the last 12 months, CANF had revenue of $743,000 and -$7.63 million in losses. Loss per share was -$0.78.

Revenue 743,000
Gross Profit 194,124
Operating Income -2.14M
Pretax Income -1.99M
Net Income -7.63M
EBITDA -1.97M
EBIT -1.99M
Loss Per Share -$0.78
Full Income Statement

Balance Sheet

The company has $2.33 million in cash and $10,451 in debt, giving a net cash position of $2.32 million or $0.42 per share.

Cash & Cash Equivalents 2.33M
Total Debt 10,451
Net Cash 2.32M
Net Cash Per Share $0.42
Equity / Book Value 1.63M
Book Value Per Share 0.30
Working Capital 2.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.21 million and capital expenditures -$523, giving a free cash flow of -$2.21 million.

Operating Cash Flow -2.21M
Capital Expenditures -523
Free Cash Flow -2.21M
FCF Per Share -$0.52
Full Cash Flow Statement

Margins

Gross margin is 26.13%, with operating and profit margins of -288.17% and -1,027.46%.

Gross Margin 26.13%
Operating Margin -288.17%
Pretax Margin -268.44%
Profit Margin -1,027.46%
EBITDA Margin -264.61%
EBIT Margin -268.44%
FCF Margin -296.86%

Dividends & Yields

CANF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -131.13%
Shareholder Yield -131.13%
Earnings Yield -70.34%
FCF Yield -20.32%
Dividend Details

Analyst Forecast

The average price target for CANF is $18.00, which is 809.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target $18.00
Price Target Difference 809.09%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 9, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date Jan 9, 2023
Split Type Reverse
Split Ratio 1:10

Scores

CANF has an Altman Z-Score of -16.85 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -16.85
Piotroski F-Score 4